U-76807

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameU-76807
Drug Alias NameU-76807
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcyl coenzyme A:cholesterol acyltransferase 2 inhibitorsAcyl coenzyme A:cholesterol acyltransferase 1 inhibitors
TargetsAcyl coenzyme A:cholesterol acyltransferase 1Acyl coenzyme A:cholesterol acyltransferase 2
Therapy Area/IndicationsHyperlipidemiasAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A